PhD Student in Cancer Immunology and Leukemia Stem Cell Biology

Angaben für Stepstone/LDAD – Please modify but do not forget itemprops and data-type=“section-title“: itemprop=“hiringOrganization“, itemprop=“responsibilities“, itemprop=“qualifications“ are mandatory; itemprop=“incentives“ and itemprop=“contact“ are optional

About the position

UniBE is ambitious.

With us, you deliver top performance and test your skills against the best.

Responsibilities

• Investigate interactions of LSCs with NK cells and B cells.
• Perform flow cytometry, cell sorting, co-culture and functional assays.
• Analyze transcriptomic and multi-omics data.
• Validate findings in vitro and in preclinical mouse models.
• Present results and contribute to publications.

For more information about our research, please see our recent publications (PMIDs: 38941612, 37643244, 30877275).

Requirements

• MSc in biological sciences, immunology, molecular biology, medicine or related field.
• Experience with cell culture, RT-qPCR and flow cytometry.
• Transcriptomics, R and mouse-model experience are advantages.
• Good English communication skills.
• Scientific curiosity, analytical thinking, and the ability to work independently and collaboratively.

Benefits

• Salary according to SNF regulations, technologies, patient samples
• Strong research infrastructure and international network
• Collaborative environment and ambitious team
• Central location in the heart of Bern

Application

Please email a motivation letter, CV, academic transcripts and contact details of two referees (preferably as one PDF) to ramin.radpour@unibe.ch

Application

More Information
Job-Abo
Application Process

Project description

• Investigation of molecular and cellular interactions between leukemia stem cells (LSCs) and immune cells, with a particular focus on acute myeloid leukemia (AML).
• We aim to understand how these interactions influence leukemia progression, immune responses, and therapeutic resistance.
• Our research combines molecular biology, immunology, multi-omics approaches including primary patient samples, and preclinical mouse models to identify potential targets for novel immunotherapeutic strategies.